The complex world of protein production just got a new tool, as Andon Bio, a startup building an early warning system for protein expression failure, announced it has raised $250K in seed funding. The company aims to make the supply and demand of translational resources visible for the first time at the molecular level.
Andon Bio's technology, developed at the University of Colorado Anschutz Medical Campus, uses a nanopore sequencing method to directly measure tRNA charging. This molecular signal reveals whether cells have the necessary resources for efficient protein production, powering a predictive engine that helps companies improve yield and cut costly development cycles.
